| scholarly article | Q13442814 |
| P356 | DOI | 10.1021/JM00396A012 |
| P698 | PubMed publication ID | 3336035 |
| P2093 | author name string | Karl J | |
| Gust R | |||
| Schneider MR | |||
| Wrobel KH | |||
| Engel J | |||
| Schönenberger H | |||
| Spruss T | |||
| Lux F | |||
| Haeberlin ST | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 72-83 | |
| P577 | publication date | 1988-01-01 | |
| P1433 | published in | Journal of Medicinal Chemistry | Q900316 |
| P1476 | title | Ring-substituted [1,2-bis(4-hydroxyphenyl)ethylenediamine]dichloroplatinum (II) complexes: compounds with a selective effect on the hormone-dependent mammary carcinoma | |
| P478 | volume | 31 |
| Q71879720 | 1,3‐Diphenylpropane‐1,3‐diamines, VI: DNA‐Interaction, Estrogen Receptor Affinity, and Cytostatic Activity of 1,3‐Diphenylpropane‐1,3‐diamine‐Pt(II) Complexes |
| Q42808049 | A rapid luciferase transfection assay for transcription activation effects and stability control of estrogenic drugs in cell cultures |
| Q70524560 | Antitumour activity of miltefosine alone and after combination with platinum complexes on MXT mouse mammary carcinoma models |
| Q41389982 | Chemical stability, biological activity and cellular uptake of a cisplatin analogue having a 1,2-diarylethyleneamine ligand in cultures of human breast cancer cells |
| Q41645742 | Chemosensitivity of human MCF-7 breast cancer cells to diastereoisomeric diaqua(1,2-diphenylethylenediamine) platinum(II) sulfates and specific platinum accumulation |
| Q67990470 | Chlorocarbamate-mustard-linked 1,1,2-triphenylbut-1-enes with a selective antitumor activity on mammary tumors containing estrogen receptors |
| Q71613662 | Combinations of interferon with platinum complexes: synergistic and antagonistic effects on growth inhibition of MCF-7 and MDA-MB231 breast cancer cells |
| Q39651734 | Design, synthesis and biological evaluation of estradiol-PEG-linked platinum(II) hybrid molecules: Comparative molecular modeling study of three distinct families of hybrids |
| Q39459674 | Development of 2,3,5-triaryl-1H-pyrroles as estrogen receptor α selective ligands |
| Q71665948 | Discrepancy between cytotoxicity, platinum accumulation, and DNA platination in MCF-7 breast cancer cells treated with diaqua (1,2-diphenylethylenediamine) platinum (II) sulfates and cisplatin |
| Q61454968 | Easy Derivatisation of Group 10 N-Heterocyclic Carbene Complexes and In Vitro Evaluation of an Anticancer Oestradiol Conjugate |
| Q43218007 | Efficient synthetic access to the hetisine C20-diterpenoid alkaloids. A concise synthesis of nominine via oxidoisoquinolinium-1,3-dipolar and dienamine-Diels-Alder cycloadditions |
| Q40778803 | Estrogen and progesterone receptor proteins in patients with breast cancer |
| Q68488459 | Influence of ring substituents on the antitumor effect of dichloro(1,2-diphenylethylenediamine)platinum(II) complexes |
| Q36364465 | Metal complex SERMs (selective oestrogen receptor modulators). The influence of different metal units on breast cancer cell antiproliferative effects |
| Q71879734 | Reduction of the Estrogenic Side Effects of the Mammary Tumor‐Inhibiting Drug [1,2‐Bis(2,6‐dichloro‐4‐hydroxyphenyl)‐ethylenediamine]dichloroplatinum(II) by Variation of Ring Substituents |
| Q39439792 | SAR study of tyrosine-chlorambucil hybrid regioisomers; synthesis and biological evaluation against breast cancer cell lines |
| Q39460986 | Synthesis, characterisation and biological evaluation of copper and silver complexes based on acetylsalicylic acid |
| Q40810835 | Synthesis, conformational studies, and investigations on the estrogen receptor binding of [R/S-1-(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]platinum(II) complexes |
| Q28066801 | The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs |
| Q40223467 | The presence of a ferrocenyl unit on an estrogenic molecule is not always sufficient to generate in vitro cytotoxicity. |
| Q31158638 | Tumor inhibiting [1,2-bis(difluorophenyl)ethylenediamine]dichloroplatinum (II) complexes, I: Synthesis |
| Q70501178 | [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]- dichloroplatinum(II), a new drug not only parenterally but also orally active in the therapy of breast and prostate cancer |
Search more.